Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

By Hoar F.J.   Chaudhri S.   Wadley M.S.   Stonelake P.S.  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1698-1703

Elsevier

Access to resources Recommend Favorite

c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma

By Akamatsu M.   Matsumoto T.   Oka K.   Yamasaki S.   Sonoue H.   Kajiyama Y.   Tsurumaru M.   Sasai K.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1323-1327

Elsevier

Access to resources Recommend Favorite

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

By Gu Aiqin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 78-80

Springer Publishing Company

Access to resources Recommend Favorite

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

By Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder - A Southwest Oncology Group Study

By Lamm D.L.   Blumenstein B.A.   Crawford E.D.   Crissman J.D.   Lowe B.A.   Smith J.A.   Sarosdy M.F.   Schellhammer P.F.   Sagalowsky A.I.   Messing E.M.   Loehrer P.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite